vimarsana.com

Page 52 - சிட்டி குழுமம் உலகளாவிய சந்தைகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rain Therapeutics Announces Pricing of Initial Public Offering

Rain Therapeutics Announces Pricing of Initial Public Offering April 22, 2021 19:03 ET | Source: Rain Therapeutics Inc Rain Therapeutics Inc Newark, California, UNITED STATES NEWARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today announced the pricing of its initial public offering of 7,352,941 shares of common stock at a public offering price of $17.00 per share. The gross proceeds to Rain from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Rain, are expected to be approximately $125.0 million. All of the shares are being offered by Rain. The shares are expected to begin trading on The Nasdaq Global Select Market on April 23, 2021 under the ticker symbol “RAIN.” In addition, Rain has granted the underwriters a 30-day option to purchase up to an addition

Freddie Mac Prices $1 4 Billion Multifamily K-Deal, K-128

Freddie Mac Prices $1.4 Billion Multifamily K-Deal, K-128 MCLEAN, Va., April 22, 2021 (GLOBE NEWSWIRE) Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 10-year terms. The company expects to issue approximately $1.4 billion in K Certificates (K-128 Certificates), which are expected to settle on or about April 29, 2021. K-128 Pricing Co-Lead Managers and Joint Bookrunners: Morgan Stanley & Co. LLC and Cantor Fitzgerald & Co. Co-Managers: Brean Capital, LLC, Citigroup Global Markets Inc., Samuel A. Ramirez & Company, Inc. and Wells Fargo Securities, LLC Rating Agencies: Fitch Ratings, Inc. and DBRS, Inc.

VPC Impact Acquisition Holdings III, Inc  : Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing April 26, 2021

VPC Impact Acquisition Holdings III, Inc  : Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing April 26, 2021
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Gores Guggenheim, Inc Announces Closing of Over-Allotment in Connection With Its Initial Public Offering

Gores Guggenheim, Inc Announces Closing of Over-Allotment in Connection With Its Initial Public Offering
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

Nachrichtenquelle: globenewswire  |  21.04.2021, 01:40  |  102   |  0  SHANGHAI and SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 4,776,000 American depositary shares (“ADSs”), each representing one ordinary share of the Company, at a price of US$150.00 per ADS, and 224,000 ordinary shares, at a price of HK$1164.20 per ordinary share, which will be settled in Hong Kong dollars, based upon each ADS representing one ordinary share and an exchange rate of HK$7.7613 to US$1.00, the spot rate of exchange at the time of pricing.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.